Johnson & Johnson’s Tremfya (guselkumab) has been FDA-approved for Crohn’s disease, joining IL-23 class peers Skyrizi and Omvoh. Backed by…
Browsing: Clinical Updates
Exact Sciences has launched Cologuard Plus™, a new FDA-approved, noninvasive colorectal cancer (CRC) screening test for average-risk adults aged 45+.…
For patients with irritable bowel syndrome with constipation (IBS-C), education is central to adherence to therapy and improved outcomes. Working…
AGA has partnered with Beyond Celiac, the leading nonprofit organization dedicated to finding a cure for celiac disease, to establish…
The FDA has approved Tremfya (guselkumab) for moderate to severe Crohn’s disease, offering a convenient at-home self-injection option in addition…
The 13th Gut Microbiota for Health World Summit revealed how cutting-edge research on gut microbiome science is being applied to…
A new study published in The American Journal of Gastroenterology shows that using WATS-3D, a wide-area transepithelial sampling tool with…
This first-ever ACG guideline addresses gastric premalignant conditions—including atrophic gastritis, gastric intestinal metaplasia (GIM), dysplasia, and certain epithelial polyps—due to…
Guardant Health’s Shield™ blood test for colorectal cancer (CRC) screening is now covered with no copay for U.S. veterans and…
PathAI announced that its AIM-MASH AI Assist tool is now the first and only AI-assisted pathology assessment technology qualified by…